ELVIS CUEVAS

Dr. ELVIS CUEVAS

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
ZKZahra Kolahchi
Zahra Kolahchi
NHNicholas Henkel
Nicholas Henkel
MEMahmoud Eladawi
Mahmoud Eladawi
EVEmma Villarreal
Emma Villarreal
PKPrathik Kandimalla
Prathik Kandimalla
ECELVIS CUEVAS
ELVIS CUEVAS
Two-thirds of Americans with Alzheimer’s disease are women, indicating a profound variance between the sexes. Variances exist between the sexes in the age and intensity of the presentation, cognitive deficits, neuroinflammatory factors, structural and functional brain changes, as well as psychosocial and cultural circumstances. Herein, we summarize the existing evidence for sexual dimorphism and present the available evidence for these distinctions. Understanding these complexities is critical to developing personalized interventions for the prevention, care, and treatment of Alzheimer’s disease.

27 August 2020 in Metabolic Brain Disease
Verified
Journal Article
Closed access
PDF file
Sumit SarkarSumit Sarkar
Sumit Sarkar
JRJames Raymick
James Raymick
ECELVIS CUEVAS
ELVIS CUEVAS
HRHector Rosas-Hernandez
Hector Rosas-Hernandez
JHJoseph Hanig
Joseph Hanig

1 March 2011 in Neurotoxicology and Teratology
Verified
Journal Article
Closed access
ECELVIS CUEVAS
ELVIS CUEVAS
SLSusan M. Lantz
Susan M. Lantz
JTJ. César Tobón-Velasco
J. César Tobón-Velasco
GNGlenn D. Newport
Glenn D. Newport
QWQiangen Wu
Qiangen Wu
ASAbel Santamaria
Abel Santamaria

21 May 2019 in Current Alzheimer Research
Verified
Journal Article
Closed access
PDF file
HRHector Rosas-Hernandez
Hector Rosas-Hernandez
ECELVIS CUEVAS
ELVIS CUEVAS
JRJames B. Raymick
James B. Raymick
BRBonnie L. Robinson
Bonnie L. Robinson
SASyed F. Ali
Syed F. Ali
Sumit SarkarSumit Sarkar
Sumit Sarkar
Background: Alzheimer’s Disease (AD) is the most common type of dementia characterized by amyloid plaques containing Amyloid Beta (Aβ) peptides and neurofibrillary tangles containing tau protein. In addition to neuronal loss, Cerebral Amyloid Angiopathy (CAA) commonly occurs in AD. CAA is characterized by Aβ deposition in brain microvessels. Recent studies have suggested that exosomes (cell-derived vesicles containing a diverse cargo) may be involved in the pathogenesis of AD. Objective: Isolate and characterize brain-derived exosomes from a transgenic mouse model of AD that presents CAA. Methods: Exosomes were isolated from serum obtained from 13-month-old wild type and AD transgenic female mice using an exosome precipitation solution. Characterization of exosomal proteins was performed by western blots and dot blots. Results: Serum exosomes were increased in transgenic mice compared to wild types as determined by increased levels of the exosome markers flotillin and alix. High levels of neuronal markers were found in exosomes, without any difference any between the 2 groups. Markers for endothelial-derived exosomes were decreased in the transgenic model, while astrocytic-derived exosomes were increased. Exosome characterization showed increased levels of oligomeric Aβ and oligomeric and monomeric forms tau on the transgenic animals. Levels of amyloid precursor protein were also increased. In addition, pathological and phosphorylated forms of tau were detected, but no difference was observed between the groups. Conclusion: These data suggest that monomeric and oligomeric forms of Aβ and tau are secreted into serum via brain exosomes, most likely derived from astrocytes in the transgenic mouse model of AD with CAA. Studies on the implication of this event in the propagation of AD are underway.